A spinal cord intravascular lymphomatosis with exceptionally good outcome.
Debiais
S
S
Department of Neurology, University Hospital, Tours, France.
Bonnaud
I
I
Cottier
J P
JP
Destrieux
C
C
Saudeau
D
D
de Toffol
B
B
Arbion
F
F
Benboubker
L
L
Autret
A
A
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002196:Capillaries / Q000473:pathology; D002330:Carmustine / Q000627:therapeutic use; D002490:Central Nervous System / Q000098:blood supply*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D008279:Magnetic Resonance Imaging; D008727:Methotrexate / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D010264:Paraplegia / Q000209:etiology; D013120:Spinal Cord Neoplasms / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D013713:Teniposide / Q000627:therapeutic use
D013713:Teniposide; D002330:Carmustine; D008775:Methylprednisolone; D008727:Methotrexate